| Literature DB >> 32963638 |
Samah A Moawd1, Alshimaa R Azab2,3, Zizi M Ibrahim4,5, Anju Verma3, Walid Kamal Abdelbasset3,6.
Abstract
OBJECTIVES: Congenital diaphragmatic hernia (CDH) is a birth defect affecting the respiratory functions, functional performance, and quality of life (QOL) in school-aged children. Rarely have studies been conducted to evaluate the impacts of respiratory muscle training on school-aged children with postoperative CDH. The current study was designed to evaluate the impacts of respiratory muscle training on respiratory function, maximal exercise capacity, functional performance, and QOL in these children.Entities:
Mesh:
Year: 2020 PMID: 32963638 PMCID: PMC7492875 DOI: 10.1155/2020/8829373
Source DB: PubMed Journal: Dis Markers ISSN: 0278-0240 Impact factor: 3.434
Figure 1The flow diagram of the study participants through the trial.
Demographic data of the study children.
| Variables | Study group ( | Control group ( |
|
|---|---|---|---|
| Age (years) | 10.1 ± 0.7 | 9.8 ± 0.8 | 0.215 |
| Gender, boys/girls ( | 11/9 | 13/7 | 0.518 |
| Height (cm) | 137.5 ± 5.9 | 135.8 ± 5.4 | 0.347 |
| Weight (kg) | 42.6 ± 4.2 | 41.8 ± 4.7 | 0.573 |
| BMI (kg/m2) | 23.2 ± 3.8 | 23.5 ± 3.6 | 0.799 |
| Duration of hospitalization (days) | 52.4 ± 7.5 | 49.8 ± 7.2 | 0.271 |
| Medications, | |||
| Low/moderate dose of inhaled corticosteroid | 5 (25) | 8 (40) | 0.311 |
| Long-acting | 15 (75) | 12 (60) |
Significant level at p < 0.05. BMI: body mass index.
Intra- and intergroup changes of outcome variables pre- and posttreatment.
| Variables | Study group ( | Control group ( |
|
|---|---|---|---|
| FVC (% pred.) | |||
| Pre- | 78.5 ± 9.8 | 78.9 ± 10.5 | 0.891 |
| Post- | 93.2 ± 7.4 | 85.8 ± 11.3 | 0.019 |
| | <0.001 | 0.053 | |
| FEV1 (% pred.) | |||
| Pre- | 72.3 ± 8.5 | 72.7 ± 9.2 | 0.887 |
| Post- | 82.6 ± 7.2 | 77.4 ± 8.8 | 0.047 |
| | 0.002 | 0.107 | |
| VO2max (mL/kg/min) | |||
| Pre- | 40.3 ± 7.4 | 40.7 ± 8.1 | 0.871 |
| Post- | 49.1 ± 7.9 | 43.5 ± 8.4 | 0.036 |
| | 0.008 | 0.290 | |
| VE/VCO2 slope | |||
| Pre- | 31.6 ± 7.1 | 30.9 ± 6.8 | 0.752 |
| Post- | 24.5 ± 5.8 | 28.7 ± 6.2 | 0.033 |
| | 0.002 | 0.291 | |
| 6-MWT | |||
| Pre- | 421.3 ± 38.7 | 438.4 ± 44.5 | 0.203 |
| Post- | 488.5 ± 42.8 | 454.6 ± 51.2 | 0.028 |
| | <0.001 | 0.292 | |
| PedsQL (overall score) | |||
| Pre- | 75.41 ± 12.5 | 72.84 ± 11.9 | 0.509 |
| Post- | 82.73 ± 11.2 | 73.52 ± 11.7 | 0.015 |
| | <0.001 | 0.632 | |
FVC: forced vital capacity; FEV1: forced expiratory volume in one second; VO2max: maximal oxygen uptake; VE/VCO2: minute ventilation/carbon dioxide production; 6-MWT: six-minute walk test; PedsQL: pediatric quality of life inventory.
Figure 2The percent of changes in the two groups posttreatment.